Tumor margins, lobulation sign, diffusion-weighted imaging appearance, MRI-reported axillary lymph node metastasis, time to signal intensity curve pattern, and HER-2 were selected as predictors for LVI in the point-based scoring system. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.